Cointime

Drug Abuse Sciences

company

About

Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions.

Highlights

Total Funding Amount
$25.65M
Funding Rounds
3
Investors
3

Details

Last Funding Type
Grant
Last Funding Money Raised
$0.95M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 1994
Operating Status
Active

Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions. It offers Naltrexone Depot, a sustained-release formulation of Naltrexone for the treatment of alcohol and opiate addictions; DAS-431 for the treatment of cocaine addiction; and Buprenorphine Depot, a sustained-release formulation of buprenorphine for the treatment of heroin and various opiate addictions.

Drug Abuse Sciences is based in Menlo Park, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$25.65M
Drug Abuse Sciences has raised a total of $25.65M in funding over 2 rounds. Their latest funding was raised on Nov 23, 1999 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 23, 1999 Grant $0.95M 1 — — Detail
Oct 28, 1999 Series Unknown $22.40M 2 — — Detail
Apr 7, 1999 Series Unknown $2.30M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Drug Abuse Sciences is funded by 3 investors. National Institutes of Health and Financiere de Brienne are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Grant
Financiere de Brienne — Series Unknown
Nomura International — Series Unknown
Cointime
เนื้อหา
บริษัท